Skip to main content
Clinical Trials/ISRCTN65795273
ISRCTN65795273
Completed
Phase 3

A study to evaluate the results of integrative treatment (Ayurvedic capsules Suved and Reimmugen) for vascular disease

Health Solutions0 sites200 target enrollmentNovember 7, 2016

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Vascular disease, atherosclerosis
Sponsor
Health Solutions
Enrollment
200
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 7, 2016
End Date
September 1, 2018
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Health Solutions

Eligibility Criteria

Inclusion Criteria

  • Males or females aged 18 or over with a diagnosis of vascular disease leading to IHD, CAD, CVD, DVT or PAD at any stage

Exclusion Criteria

  • 1\. Pregnant and lactating women
  • 2\. Patients below age of 18
  • 3\. Acute IPD operative condition
  • 4\. Patients undergoing interventional procedures/surgical treatments other than for vascular disease, until they are discharged from intensive care
  • 5\. Haemorrhagic cerebrovascular stroke

Outcomes

Primary Outcomes

Not specified

Similar Trials